PCMTD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.540000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.408800E-01
Normal-vs-Stage2
2.511600E-01
Normal-vs-Stage3
1.251360E-01
Normal-vs-Stage4
8.169000E-01
Stage1-vs-Stage2
9.917800E-01
Stage1-vs-Stage3
5.416200E-01
Stage1-vs-Stage4
6.112000E-01
Stage2-vs-Stage3
4.597600E-01
Stage2-vs-Stage4
4.128600E-01
Stage3-vs-Stage4
3.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.042000E-01
Normal-vs-AfricanAmerican
4.847000E-01
Normal-vs-Asian
3.542600E-01
Caucasian-vs-AfricanAmerican
5.710200E-01
Caucasian-vs-Asian
7.589800E-01
AfricanAmerican-vs-Asian
5.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.225800E-01
Normal-vs-Female
3.170200E-01
Male-vs-Female
4.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.199200E-01
Normal-vs-Age(41-60Yrs)
3.850800E-01
Normal-vs-Age(61-80Yrs)
2.472600E-01
Normal-vs-Age(81-100Yrs)
6.381800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.231000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.422600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.920400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.399000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.116600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.371990E-01
Normal-vs-Daily Drinker
1.361020E-01
Normal-vs-Weekly Drinker
7.944400E-02
Normal-vs-Occasional Drinker
6.056400E-01
Normal-vs-Social Drinker
4.079200E-01
Non Drinker-vs-Daily Drinker
3.416000E-01
Non Drinker-vs-Weekly Drinker
2.428200E-01
Non Drinker-vs-Occasional Drinker
3.297000E-01
Non Drinker-vs-Social Drinker
6.852800E-01
Daily Drinker-vs-Weekly Drinker
8.371200E-01
Daily Drinker-vs-Occasional Drinker
1.226960E-01
Daily Drinker-vs-Social Drinker
3.244600E-01
Weekly Drinker-vs-Occasional Drinker
1.144650E-01
Weekly Drinker-vs-Social Drinker
2.696000E-01
Occasional Drinker-vs-Social Drinker
6.294400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.590000E-02
Normal-vs-Grade 2
8.061400E-03
Normal-vs-Grade 3
1.022400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.628400E-01
Grade 1-vs-Grade 3
5.656000E-01
Grade 1-vs-Grade 4
2.590000E-02
Grade 2-vs-Grade 3
6.650200E-01
Grade 2-vs-Grade 4
8.061400E-03
Grade 3-vs-Grade 4
1.022400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.052200E-01
Normal-vs-NonDiabetic
1.911990E-01
Diabetic-vs-NonDiabetic
7.154400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.041800E-02
Normal-vs-NoPancreatitis
2.332200E-01
Pancreatitis-vs-NoPancreatitis
3.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.403000E-01
Normal-vs-N1
2.909400E-01
N0-vs-N1
4.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.247000E-01
Normal-vs-TP53-NonMutant
4.795800E-01
TP53-Mutant-vs-TP53-NonMutant
6.673800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
